Abstract
A chromogenic assay for use as a screening test for the identification of antithrombin deficiency is described. The heparin concentration and the incubation time in the assay were optimised specifically to permit the detection of heparin binding defects of antithrombin. The sensitivity of antithrombin assays for the detection of this type of variant was significantly impaired when an incubation time of more than 30 seconds was used. Several commercially available assays recommend a longer incubation time than 30 seconds and therefore some patients with heparin binding defects of antithrombin may not be identified. The assay described here allows heparin binding variants of antithrombin to be identified and distinguished from other types of antithrombin deficiency in a simple two stage procedure.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abildgaard U., Lie M., Odegård O. R. Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). Thromb Res. 1977 Oct;11(4):549–553. doi: 10.1016/0049-3848(77)90208-0. [DOI] [PubMed] [Google Scholar]
- Owen M. C., Borg J. Y., Soria C., Soria J., Caen J., Carrell R. W. Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His. Blood. 1987 May;69(5):1275–1279. [PubMed] [Google Scholar]
- Prochownik E. V. Molecular genetics of inherited antithrombin III deficiencies. Am J Med. 1989 Sep 11;87(3B):15S–18S. doi: 10.1016/0002-9343(89)80525-x. [DOI] [PubMed] [Google Scholar]
- Rosenberg R. D. Actions and interactions of antithrombin and heparin. N Engl J Med. 1975 Jan 16;292(3):146–151. doi: 10.1056/NEJM197501162920307. [DOI] [PubMed] [Google Scholar]
- Thaler E., Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol. 1981 Jun;10(2):369–390. [PubMed] [Google Scholar]